Deep-pocketed investors have adopted a bullish approach towards Moderna (NASDAQ:MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 32 extraordinary options activities for Moderna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 37% bearish. Among these notable options, 7 are puts, totaling $556,704, and 25 are calls, amounting to $2,114,502.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $180.0 for Moderna over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $90.0 to $180.0 in the last 30 days.
Moderna Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | CALL | TRADE | NEUTRAL | 01/17/25 | $46.95 | $42.7 | $44.85 | $130.00 | $358.8K | 1.3K | 80 |
MRNA | PUT | TRADE | BEARISH | 01/17/25 | $14.7 | $14.4 | $14.7 | $140.00 | $294.0K | 428 | 1 |
MRNA | CALL | SWEEP | BULLISH | 01/16/26 | $75.3 | $68.2 | $72.73 | $110.00 | $290.8K | 168 | 40 |
MRNA | CALL | SWEEP | NEUTRAL | 05/31/24 | $21.7 | $20.45 | $21.05 | $140.00 | $210.5K | 693 | 101 |
MRNA | CALL | TRADE | NEUTRAL | 01/16/26 | $49.9 | $43.75 | $47.37 | $160.00 | $189.4K | 455 | 0 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Moderna's Current Market Status
- With a volume of 1,393,780, the price of MRNA is down -2.28% at $159.61.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 70 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
财力雄厚的投资者对Moderna(NASDAQ:MRNA)采取了看涨态度,这是市场参与者不容忽视的。我们对本辛加公开期权记录的追踪今天揭示了这一重大举措。这些投资者的身份仍然未知,但是MRNA的如此重大变动通常表明即将发生重大事件。
我们今天从观察中收集了这些信息,当时Benzinga的期权扫描仪重点介绍了Moderna的32项非同寻常的期权活动。这种活动水平与众不同。
这些重量级投资者的总体情绪存在分歧,43%的人倾向于看涨,37%的人倾向于看跌。在这些值得注意的期权中,有7个是看跌期权,总额为556,704美元,25个是看涨期权,总额为2,114,502美元。
目标价格是多少?
根据交易活动,看来主要投资者的目标是在最近三个月中将Moderna的价格范围从90.0美元扩大到180.0美元。
交易量和未平仓合约趋势
在交易期权时,查看交易量和未平仓合约是一个强有力的举动。这些数据可以帮助您跟踪给定行使价下Moderna期权的流动性和利息。下面,我们可以分别观察过去30天中Moderna所有鲸鱼交易的看涨期权和看跌期权交易量和未平仓合约的变化,其行使价在90.0美元至180.0美元之间。
Moderna 期权活动分析:过去 30 天
发现的最大选择:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | CALL | TRADE | NEUTRAL | 01/17/25 | $46.95 | $42.7 | $44.85 | $130.00 | $358.8K | 1.3K | 80 |
MRNA | PUT | TRADE | BEARISH | 01/17/25 | $14.7 | $14.4 | $14.7 | $140.00 | $294.0K | 428 | 1 |
MRNA | CALL | SWEEP | BULLISH | 01/16/26 | $75.3 | $68.2 | $72.73 | $110.00 | $290.8K | 168 | 40 |
MRNA | CALL | SWEEP | NEUTRAL | 05/31/24 | $21.7 | $20.45 | $21.05 | $140.00 | $210.5K | 693 | 101 |
MRNA | CALL | TRADE | NEUTRAL | 01/16/26 | $49.9 | $43.75 | $47.37 | $160.00 | $189.4K | 455 | 0 |
关于 Moderna
Moderna是一家商业阶段的生物技术公司,成立于2010年,并于2018年12月进行了首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得授权。截至2023年中期,Moderna在临床试验中有39个mRNA开发候选药物。项目涵盖广泛的治疗领域,包括传染病、肿瘤学、心血管疾病和罕见遗传病。
鉴于Moderna最近的期权历史,现在应该专注于公司本身。我们的目标是探索其目前的表现。
Moderna 的当前市场状况
与仅交易股票相比,期权是一种风险更高的资产,但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。